These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12598857)

  • 1. Three questions about costs and cancer clinical trials.
    Chirikos TN
    Cancer Control; 2003; 10(1):71-8. PubMed ID: 12598857
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient costs on clinical trials.
    Presant CA
    J Natl Cancer Inst; 2000 Sep; 92(17):1441-3. PubMed ID: 10974083
    [No Abstract]   [Full Text] [Related]  

  • 3. What's cost-effective in cancer care?
    Cancer Discov; 2011 Nov; 1(6):OF1-2. PubMed ID: 22586658
    [No Abstract]   [Full Text] [Related]  

  • 4. Costs studies show clinical trials, standard therapy may be equal.
    Reynolds T
    J Natl Cancer Inst; 2000 Jul; 92(14):1116-8. PubMed ID: 10904079
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
    Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
    J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reimbursement issues facing patients, providers, and payers.
    Antman K
    Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement for patients enrolled in clinical trials.
    Kennedy BJ
    Cancer Invest; 1994; 12(4):444-6. PubMed ID: 8032968
    [No Abstract]   [Full Text] [Related]  

  • 8. Incremental treatment costs in national cancer institute-sponsored clinical trials.
    Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
    JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paying for patient care in treatment research--who is responsible?
    Wittes RE
    Cancer Treat Rep; 1987 Feb; 71(2):107-13. PubMed ID: 3100033
    [No Abstract]   [Full Text] [Related]  

  • 11. Payer coverage for patients enrolled onto clinical trials: making the process easy and transparent for everyone.
    Palackdharry CS; Evans DL; McDonough RS; Clarke ME; Cross JD; Klein IM; Reisman L
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP91-7. PubMed ID: 22693988
    [No Abstract]   [Full Text] [Related]  

  • 12. Reimbursement issues in cancer clinical trials.
    McKenna RJ
    Cancer; 1990 May; 65(10 Suppl):2405-6. PubMed ID: 2346567
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of Cancer Value Frameworks for Patients, Payers, and Physicians.
    Chandra A; Shafrin J; Dhawan R
    JAMA; 2016 May; 315(19):2069-70. PubMed ID: 27187295
    [No Abstract]   [Full Text] [Related]  

  • 14. The crisis in clinical cancer research. Third-party insurance and investigational therapy.
    Antman K; Schnipper LE; Frei E
    N Engl J Med; 1988 Jul; 319(1):46-8. PubMed ID: 3288868
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation Oncology Clinical Trial Design: An Opportunity to Evaluate Value.
    Shah C; Ward M; Singer ME
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):674-675. PubMed ID: 31540597
    [No Abstract]   [Full Text] [Related]  

  • 16. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More states mandate coverage of clinical trial costs, but does it make a difference?
    McBride G
    J Natl Cancer Inst; 2003 Sep; 95(17):1268-9. PubMed ID: 12953076
    [No Abstract]   [Full Text] [Related]  

  • 18. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost: the new factor clinical cancer investigators must learn to consider.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(5):263-4. PubMed ID: 8440742
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.